Publication | Closed Access
A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: A study of the EORTC Early Clinical Studies Group (ECSG)
43
Citations
3
References
1996
Year
Non-small-cell Lung CancerNovel Indoloquinone Eo9MedicineCancer ManagementPharmacologyBronchial NeoplasmAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyLung CancerCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1